Thursday, April 25th | 17 Nisan 5784

Subscribe
July 31, 2017 10:28 am
0

Israel Closely Monitoring Palestinian Authority Leader Abbas’ ‘Deteriorating’ Health

× [contact-form-7 404 "Not Found"]

avatar by JNS.org

Palestinian Authority President Mahmoud Abbas during a past UN General Assembly address. Photo: Screenshot.

JNS.org – Israel’s security establishment is closely monitoring the health condition of Palestinian Authority (PA) President Mahmoud Abbas, after he was hospitalized this weekend at the Al Istishari Hospital near Ramallah.

At the hospital, Abbas reportedly underwent “routine checks” including blood tests and X-rays. The hospital’s director, Dr. Fathi Abu Mughli, stated that the PA leader left after 90 minutes, The Associated Press reported.

“The results are good,” said Mughli, without elaborating.

PA officials stated that Abbas, 82, was admitted to hospital after suffering from fatigue caused by the stressful events of the past two weeks concerning the Temple Mount.

Throughout the 13-day crisis, Abbas purportedly endured a far more rigorous schedule than usual in order to keep up with the rapidly unfolding events and maintain constant contact with Palestinian, Arab and Western officials.

Both Israeli and Palestinian sources assessed that Abbas’s health has deteriorated during recent months and could hasten the process of choosing new PA leadership, Haaretz reported. While Israel has accused the Palestinian leader of inciting violence and terror, especially over the Temple Mount, Israel security officials also coordinate with the PA and are concerned with any power vacuums that may emerge atop the PA if Abbas were to leave office or die.

According to reports, Abbas is generally considered to be healthy, but was treated for prostate cancer during the past decade, and was also diagnosed with heart problems. In June, Abbas dismissed reports that he had suffered a stroke.

Abbas is overweight and purported to be a heavy smoker, but recently substituted his tobacco habit with electronic cigarettes.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.